The effects of local review on informed consent documents from a multicenter clinical trials consortium

被引:68
|
作者
Burman, W
Breese, P
Weis, S
Bock, N
Bernardo, J
Vernon, A
机构
[1] Denver Publ Hlth, Denver, CO 80204 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
[3] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA
[4] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA
[5] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02215 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 03期
关键词
institutional review board; consent form; human subjects protection; reading level; multicenter; clinical trials;
D O I
10.1016/S0197-2456(03)00003-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There is increasing controversy about the appropriate role of the local institutional review board in the review of multicenter clinical studies. We evaluated the effects of the local review process at 25 study sites on the consent forms from two studies of the Tuberculosis Trials Consortium, a multicenter trials group. Two independent reviewers classified all changes made in the centrally approved consent forms; a third reviewer evaluated those changes if the two initial reviewers disagreed. The median time to initial local approval was 104.5 days (range 31-346). There were no changes in the study protocols as a result of local review. Consent forms became longer and less readable after local review, with a mean increase in grade level of 0.9 (+/-0.9) reading grade levels (p < 0.001). A median of 46.5 changes (range 3-160) were made in the centrally approved forms. Most changes (85.2%) involved altering wording without affecting meaning. Errors were commonly introduced (11.2% of changes), and 33 of 50 (66%) locally approved consent forms contained at least one error in protocol presentation or a required consent form element. Local approval of two multicenter clinical trials was time-consuming and resulted in many changes in centrally approved consent forms. These changes frequently decreased readability and introduced errors. (C) 2003 by Elsevier Inc. All rights reserved.
引用
收藏
页码:245 / 255
页数:11
相关论文
共 50 条
  • [41] INFORMED CONSENT IN CLINICAL-TRIALS - FULL CONSENT MAY BIAS OUTCOME OF TRIALS
    KANIS, JA
    BERGMANN, JF
    BRITISH MEDICAL JOURNAL, 1993, 307 (6917): : 1497 - 1497
  • [42] The Problem of Readability of Informed Consent Documents for Clinical Trials of Investigational Drugs and Devices: United States Considerations
    S. Michael Sharp
    Drug information journal : DIJ / Drug Information Association, 2004, 38 (4): : 353 - 359
  • [43] A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group
    Bleiberg, H.
    Decoster, G.
    de Gramont, A.
    Rougier, P.
    Sobrero, A.
    Benson, A.
    Chibaudel, B.
    Douillard, J. Y.
    Eng, C.
    Fuchs, C.
    Fujii, M.
    Labianca, R.
    Larsen, A. K.
    Mitchell, E.
    Schmoll, H. J.
    Sprumont, D.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 922 - 930
  • [44] The problem of readability of informed consent documents for clinical trials of investigational drugs and devices: United States considerations
    Sharp, SM
    DRUG INFORMATION JOURNAL, 2004, 38 (04): : 353 - 359
  • [45] The Memorial Sloan Kettering (MSK) electronic informed consent (eIC) platform for clinical trials: An operational model and suite of tools for obtaining informed consent, and managing consent documents.
    Buckley, Michael T.
    Lengfellner, Joseph M.
    Koch, Matthew J.
    Pacheco, Hector O.
    Hoidra, Carol
    Damron, Dorothy J.
    Cambria, Roy
    Rodavitch, Ann
    Sabbatini, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] INFORMED CONSENT IN CLINICAL-TRIALS - INFORMED CONSENT DIFFICULT IN PEDIATRIC INTENSIVE-CARE
    MODI, N
    BRITISH MEDICAL JOURNAL, 1993, 307 (6917): : 1495 - 1495
  • [47] INFORMED VERSUS RANDOMIZED CONSENT TO CLINICAL-TRIALS
    GALLO, C
    PERRONE, F
    DEPLACIDO, S
    GIUSTI, C
    LANCET, 1995, 346 (8982): : 1060 - 1064
  • [48] STANDARDIZING THE PROCESS OF INFORMED CONSENT IN CLINICAL TRIALS.
    Hinckley, Patricia
    Servodidio, Camille
    Bassett, Paul
    Ward, Danytza
    Cuddy, Karen
    Cuddy, Katherine
    Opito, Rachel
    ONCOLOGY NURSING FORUM, 2013, 40 (03) : E187 - E188
  • [49] Improving informed consent in clinical trials: A duty to experiment
    Lavori, PW
    Sugarman, J
    Hays, MT
    Feussner, JR
    CONTROLLED CLINICAL TRIALS, 1999, 20 (02): : 187 - 193
  • [50] Evaluation of the written informed consent form in clinical trials
    Marrero-Alvarez, P.
    Ruiz-Ramos, J.
    Megias-Vericat, J. E.
    Tordera-Baviera, M.
    Poveda-Andres, J. L.
    REVISTA DE CALIDAD ASISTENCIAL, 2013, 28 (03) : 139 - 144